Highest-materiality recent filing
Odysight.ai launches $11M public offering of 3.4M shares at $3.20; terminates ATM
Offering: 3,437,500 shares at $3.20/share; gross proceeds ~$11M before discounts and expenses.
Odysight.ai prices $11M public offering of 3.44M common shares at $3.20
Priced 3,437,500 common shares at $3.20/share; gross proceeds expected ~$11M.
Odysight.ai H1 2026 revenue $0.5M, net loss $9.5M; backlog rises to $16.45M
Revenue $0.5M vs $2.4M YoY; drop driven by $1.86M prior-year medical customer revenue and $1.69M contract liability derecognition.
Odysight.ai enters $20M ATM sales agreement with Roth Capital Partners
Up to $20M of common stock may be sold at prevailing market prices through Roth Capital Partners as agent.
Odysight.ai Q1 revenue $82K (down 96% YoY); net loss $5.2M; backlog $14M
Revenue $82K vs $2.1M YoY; Q1 2025 included $1.7M contract liability derecognition from Fortune 500 medical customer.
Odysight.ai FY2025 revenue $3.0M, core PdM platform up 23%, backlog $13.8M
Total FY2025 revenue $3.0M (down 25% YoY) but core PdM/CBM platform revenue grew ~23% to $1.2M.
Odysight.ai CEO letter reveals ~$26M cash, $14M+ backlog, $10M UAV defense contract
Estimated cash balance ~$26M as of Dec 31, 2025, from $23.7M raised alongside NASDAQ uplisting.
Odysight.ai reports $12.8M net loss on $2.6M revenue; cash $29.8M, backlog $14.2M
Revenue $2.6M in 9M2025 vs $2.7M in 9M2024; net loss widened to $12.8M from $8.2M.
Odysight.ai H1 2025 revenue $2.4M, net loss $8.3M; cash $33.2M after uplisting
Revenue $2.4M (up 71% YoY) driven by $1.7M Fortune 500 medical contract; backlog $14.4M.
Odysight.ai Q1 revenue jumps to $2.1M from $0.2M; net loss widens to $4.3M
Revenue $2.1M (up 10x YoY) driven by $1.7M fulfillment of Fortune 500 medical contract.
Odysight.ai FY 2024 revenue $4M (+31% YoY); backlog jumps >450% to $15M
Revenue $4.0M (+31% YoY); gross margin improved to 29% from 17%.
Odysight.ai (ODYS) prices $21.5M equity offering, begins Nasdaq trading Feb 11
Offering of 3,307,692 shares at $6.50/share; gross proceeds ~$21.5M, net proceeds ~$18.8M.
Odysight.ai nine-month revenue $2.7M (+145% YoY); backlog record $16M; $10M+ defense contract
Revenue $2.7M for 9M 2024 vs $1.1M YoY, driven by higher unit sales to a Fortune 500 healthcare firm and Industry 4.0.
Odysight.ai receives purchase order >$10M from defense contractor for UAV predictive maintenance
Purchase order exceeding $10M from a leading international defense contractor for vision-based PdM system.
Odysight.ai reports H1 2024 revenue up 40% to $1.4M; net loss narrows to $5.3M
Revenue $1.4M (+40% YoY); gross profit $0.3M vs prior year gross loss $0.4M.
Odysight.ai secures $10.3M private placement of 2.14M shares at $4.80/share
Gross proceeds of $10.3M from 2,144,583 shares at $4.80 per share.
Odysight.ai Q1 2024 net loss $3.2M; backlog $3.5M; defense orders highlight growth
GAAP net loss $3.2M and non-GAAP net loss $2.7M for Q1 2024, compared to $2.7M GAAP loss in Q1 2023.
Odysight.ai 2023 revenue surges >350% to $3.0M, first gross profit of $0.5M
2023 revenue $3.0M vs $0.7M in 2022, >350% growth.
Odysight.ai receives >$1M purchase order for predictive maintenance system on IAF SH-60 Seahawk
Purchase order exceeding $1 million from major international defense contractor.
Purchase order from Israeli Ministry of Defense to deploy PdM system on IAF Boeing AH-64 Apache attack helicopter prototype.
Odysight.ai elects two new independent directors; Inbal Kreiss reelected
Stockholders representing >50% of outstanding shares voted by written consent on Dec 6, 2023 to elect two new directors and reelect one.
Odysight.ai receives $3.3M purchase order from Fortune 500 medical partner for FY2024
Expanded PO from Fortune 500 orthopaedic company totals $3.3M for fiscal year 2024.
Odysight.ai: $1.45M order, $2.5M revenue outlook, IAI Blackhawk deal, $14M placement
Purchase order of $1.45M from Fortune 500 healthcare customer; expects $2.5M revenue in 2023 from first-year product launch.
The foregoing options were awarded to Mr. Tanami, who was appointed as the Chief Operating Officer on May 13, 2026, pursuant to the Company’s 2024 Stock Incentive Plan and have an exercise price of $5.09 per share.
On September 16, 2024, the Board of Directors of Odysight.ai Inc. (the “Board” and the “Company”, respectively) appointed Dr. Carlo Papa to serve as a member of the Board
On February 21, 2024, the Board resolved to appoint Ms. Einav Brenner to serve as Chief Financial Officer of the Company, which appointment shall enter into effect on May 5, 2024.
On February 21, 2024, Odysight.ai Inc. (the “ Company ”) appointed Tanya Yosef as VP of Finance for the Company, a position she is expected to begin on May 5, 2024.
On August 13, 2023, the Board of Directors of Odysight.ai Inc. (the “Board” and the “Company”, respectively) appointed Mr. Nir Nimrodi to serve as a member of the Board.
On June 1, 2023, Ronen Rosenbloom notified ScoutCam Inc. (the “Company”) that he would resign as a member of the Board of Directors effective immediately.
On July 13, 2022, the Board resolved to appoint Mr. Yehu Ofer to serve as Chief Executive Officer of the Company, which appointment shall enter into effect on October 18, 2022.
On August 12, 2022, Roee Peled, VP of Business Development for ScoutCam Ltd. (the “Company”), resigned from his position with the Company for personal reasons, effective October 30, 2022.
On July 12, 2022, ScoutCam (the “ Company ”) and Yovav Sameah, the Chief Executive Officer of the Company, mutually agreed that Mr. Sameah’s employment with the Company would terminate on October 18, 2022.
On July 6, 2021, Issac Silberman notified ScoutCam Inc. (the “Company”) by letter that he would resign as a member of the Board of Directors effective immediately.
Max materiality 0.85 · Median 0.55 · Most common event other_material